penamecillin : A penicillanic acid ester that is the acetoxymethyl ester of benzylpenicillin. It is a prodrug for benzylpenicillin. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]
ID Source | ID |
---|---|
PubMed CID | 10250769 |
CHEMBL ID | 2106988 |
CHEBI ID | 131733 |
SCHEMBL ID | 33895 |
MeSH ID | M0066792 |
Synonym |
---|
penamecillin |
983-85-7 |
penamecillin (usan/inn) |
D05406 |
CHEBI:131733 |
penamecilline |
acetoxymethyl benzylpenicillanate |
acetoxymethyl (2s,5r,6r)-3,3-dimethyl-7-oxo-6-(2-phenylacetamido)-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate |
penamecilina |
penamecillinum |
benzylpenicillin acetoxymethyl ester |
h0p1ye5581 , |
penamecilline [inn-french] |
4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 3,3-dimethyl-7-oxo-6-((phenylacetyl)amino)-(2s-(2alpha,5alpha,6beta))-, (acetyloxy)methyl ester |
penamecillinum [inn-latin] |
penamecillina |
penamecilina [inn-spanish] |
wy 20,788 |
hydroxymethyl (2s,5r,6r)-3,3-dimethyl-7-oxo-6-(2-phenylacetamido)-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylate, acetate (ester) |
einecs 213-571-8 |
penamecillin [usan:inn:ban] |
penamecillina [dcit] |
wy-20,788 |
penicillin g, hydroxymethyl ester, acetate |
unii-h0p1ye5581 |
wy-20788 |
CHEMBL2106988 |
penamecillin [mi] |
penamecillin [usan] |
penamecillin [inn] |
penamecillin [who-dd] |
4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 3,3-dimethyl-7-oxo-6-((phenylacetyl)amino)-(2s-(2.alpha.,5.alpha.,6.beta.))-, (acetyloxy)methyl ester |
hydroxymethyl (2s,5r,6r)-3,3-dimethyl-7-oxo-6-(2-phenylacetamido)-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate, acetate (ester) |
SCHEMBL33895 |
DTXSID10243547 |
(2s,5r,6r)-acetoxymethyl 3,3-dimethyl-7-oxo-6-(2-phenylacetamido)-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate |
gtpl12808 |
havapen |
DB13739 |
acetyloxymethyl (2s,5r,6r)-3,3-dimethyl-7-oxo-6-[(2-phenylacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate |
CS-0094810 |
4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 3,3-dimethyl-7-oxo-6-[(2-phenylacetyl)amino]- (2s,5r,6r)-, (acetyloxy)methyl ester |
HY-111988 |
Role | Description |
---|---|
antibacterial drug | A drug used to treat or prevent bacterial infections. |
prodrug | A compound that, on administration, must undergo chemical conversion by metabolic processes before becoming the pharmacologically active drug for which it is a prodrug. |
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Class | Description |
---|---|
penicillanic acid ester | |
semisynthetic derivative | Any organic molecular entity derived from a natural product by partial chemical synthesis. |
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 4 (80.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 5 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |